CMB2017 First Prize small.jpg
rsc-logo.jpg
Emerging Technologies Competition
Nanomerics wins
Royal Society of Chemistry
CMB2017 First Prize small.jpg
rsc-logo.jpg
Emerging Technologies Competition
Nanomerics wins
Royal Society of Chemistry

Products

 

NM133

NM133 is a nano enabled form of cyclosporine A that is being investigated for the treatment of dry eye disease.

 

NM127

NM127 is a strong pain therapeutic based on an endogenous peptide and could replace the current opiate analgesics.

 

NM147

NM147 is a oral form of the Amphotericin B indicated for the treatment of various fungal infections and leishmaniasis.

 

Pipeline

Nanomerics has a number of other products in its development pipeline

 find out more...

Technology

 

Molecular Envelope Technology (MET)

MET is based on a proprietary polymer with tightly controlled chemical properties engineered to form defined nano-sized drug carriers.

 

Carrier Stability

MET polymers form polymeric micelles which are extremely stable, predictable and carry high API payloads.

 

Safety

MET is regarded as safe as particles gradually disintegrate resulting in complete polymer excretion.

 

Delivery

MET particles increase delivery of APIs across a number of epithelial barriers by between 5-40 fold.

find out more...

Latest News (Twitter)

RT @RoySocChem: Health prizes go to Nanomerics and Parkure Ltd. Well done! #RSCEmergingTech #CMB2017 https://t.co/gxqVWNlS14
#CMB2017 Nanomerics' CEO Andreas Schätzlein and CSO Ijeoma Uchegbu with the Chief Executive of @RoySocChem and @BBChttps://t.co/xtWxjtOyD7